Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Cohen

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
American Heart Journal|July 1, 2008
Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysisDennis T Ko, Maria Chiu, Peter C Austin, et al.
Critical Pathways in Cardiology|November 15, 2014
Pharmacodynamic and clinical implications of switching between P2Y12 receptor antagonists: considerations for practiceAkshay Bagai, Doson Chua, Eric A Cohen, et al.
The Canadian Journal of Cardiology|August 14, 2003
Risk stratification, management and outcomes of patients with non-ST elevation acute coronary syndrome: a Canadian teaching hospital perspectiveYana Shamiss, Yaariv Khaykin, John Papastergiou, et al.
Radiology|May 16, 2019
Breast Cancer Conspicuity on Simultaneously Acquired Digital Mammographic Images versus Digital Breast Tomosynthesis ImagesKatrina E Korhonen, Emily F Conant, Eric A Cohen, et al.
Journal of Virology|February 27, 2009
Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi networkMathieu Dubé, Bibhuti Bhusan Roy, Pierre Guiot-Guillain, et al.
Plos Pathogens|April 14, 2010
Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartmentMathieu Dubé, Bibhuti Bhusan Roy, Pierre Guiot-Guillain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
CD4 dimers constitute the functional component required for T cell activationMaria-Cristina Moldovan, Abdelkader Yachou, Karine Lévesque, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 12, 2016
HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated NeuroinflammationManmeet K Mamik, Elizabeth Hui, William G Branton, et al.
JACC. Cardiovascular Interventions|January 21, 2019
Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart DiseaseAndrew Czarnecki, Feng Qiu, Gabby Elbaz-Greener, et al.
Clinical and Experimental Dermatology|July 24, 2025
Risk factors for hypertrophic scar development in chest proceduresEmily R Gordon, Megan H Trager, Tessa LeWitt, et al.
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
American Heart Journal|July 1, 2008
Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysisDennis T Ko, Maria Chiu, Peter C Austin, et al.
Critical Pathways in Cardiology|November 15, 2014
Pharmacodynamic and clinical implications of switching between P2Y12 receptor antagonists: considerations for practiceAkshay Bagai, Doson Chua, Eric A Cohen, et al.
The Canadian Journal of Cardiology|August 14, 2003
Risk stratification, management and outcomes of patients with non-ST elevation acute coronary syndrome: a Canadian teaching hospital perspectiveYana Shamiss, Yaariv Khaykin, John Papastergiou, et al.
Radiology|May 16, 2019
Breast Cancer Conspicuity on Simultaneously Acquired Digital Mammographic Images versus Digital Breast Tomosynthesis ImagesKatrina E Korhonen, Emily F Conant, Eric A Cohen, et al.
Journal of Virology|February 27, 2009
Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi networkMathieu Dubé, Bibhuti Bhusan Roy, Pierre Guiot-Guillain, et al.
Plos Pathogens|April 14, 2010
Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartmentMathieu Dubé, Bibhuti Bhusan Roy, Pierre Guiot-Guillain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
CD4 dimers constitute the functional component required for T cell activationMaria-Cristina Moldovan, Abdelkader Yachou, Karine Lévesque, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 12, 2016
HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated NeuroinflammationManmeet K Mamik, Elizabeth Hui, William G Branton, et al.
JACC. Cardiovascular Interventions|January 21, 2019
Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart DiseaseAndrew Czarnecki, Feng Qiu, Gabby Elbaz-Greener, et al.
Clinical and Experimental Dermatology|July 24, 2025
Risk factors for hypertrophic scar development in chest proceduresEmily R Gordon, Megan H Trager, Tessa LeWitt, et al.
Pageof 18